跳至主要内容
临床试验/NCT05476250
NCT05476250终止不适用

Clinical Performance of Masimo INVSENSOR00057 for Atrial Fibrillation Detection

Masimo Corporation2 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年8月1日最近更新:

试验速览

阶段
不适用
状态
终止
入组人数
120
试验地点
2
主要终点
Specificity of Masimo INVSENSOR00057 Atrial Fibrillation Detection Function

研究概览

简要总结

This study is designed to validate the performance of Masimo INVSENSOR00057 in detecting atrial fibrillation. The noninvasive ECG measurements will be compared to results obtained from an FDA-cleared ECG monitor.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The subject is 18 to 80 years of age.
  • Subject can read and communicate in English.
  • Subject's cardiac rhythm shall be Normal Sinus Rhythm or Atrial Fibrillation (Afib). This determination will be made using FDA cleared 3-lead ECG which will label subject's cardiac rhythm as such.

排除标准

  • Subject has open wounds, inflamed tattoos or piercings on the area of device placement, and/or has any visible healing wounds that the investigator and/or medical professional determines may place them at an increased risk for participation.
  • Subject has any medical condition which in the judgment of the investigator and/or study staff, renders them ineligible for participation in this study or subject is deemed ineligible by the discretion of the investigator/study staff.

结局指标

主要结局

Specificity of Masimo INVSENSOR00057 Atrial Fibrillation Detection Function

时间窗: 1-5 hours

Specificity refers to the ability of Masimo INVSENSOR00057 to correctly identify individuals who do not have atrial fibrillation. High specificity is important in minimizing false positives.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Performance of Masimo INVSENSOR00057 for... | 临床试验